UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004860
Receipt number R000005661
Scientific Title A study of the endovascular treatment for the main artery occlusion after intravenous t-PA treatment
Date of disclosure of the study information 2011/02/01
Last modified on 2018/09/12 17:36:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the endovascular treatment for the main artery occlusion after intravenous t-PA treatment

Acronym

A study of the endovascular treatment after intravenous t-PA treatment

Scientific Title

A study of the endovascular treatment for the main artery occlusion after intravenous t-PA treatment

Scientific Title:Acronym

A study of the endovascular treatment after intravenous t-PA treatment

Region

Japan


Condition

Condition

Cerebral infarction within onset three hours

Classification by specialty

Cardiology Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to elucidate whether recanalization therapy by the endovascular treatment is useful in a patients with cerebral infarcition for hyper-acute phase.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Number of patients that modified Rankin's scale onset three months later is 0 to 2.

Key secondary outcomes

Symptomatic intracranial hemorrhage within onset of 24 hours
Death within onset three months
Presence of recanalization just after the endovascular treatment
NIHSS score: after treatment of 24 hours, 7days, and discharge
Other adverse effect


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

endovascular treatment

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A case with main cerebral artery (ICA, MCA, VA, BA) occlusion who has administered iv-tPA within three hours onset

Key exclusion criteria

The patient having contrast media allergy
contraindication for iv-tPA treatment

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masao Watanabe

Organization

Kawasaki Medical School

Division name

Department of stroke medicine

Zip code


Address

577 Matsushima, Kurashiki city, Okayama, Japan

TEL

086-462-1111

Email

masao-w@par.odn.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masao Watanabe

Organization

Kawasaki Medical School

Division name

Department of stroke medicine

Zip code


Address

577 Matsushima, Kurashiki city, Okayama, Japan

TEL

086-462-1111

Homepage URL


Email

masao-w@par.odn.ne.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

川崎医科大学附属病院


Other administrative information

Date of disclosure of the study information

2011 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 04 Day

Date of IRB


Anticipated trial start date

2011 Year 02 Month 01 Day

Last follow-up date

2011 Year 02 Month 16 Day

Date of closure to data entry

2011 Year 02 Month 16 Day

Date trial data considered complete

2011 Year 02 Month 16 Day

Date analysis concluded

2011 Year 02 Month 16 Day


Other

Other related information



Management information

Registered date

2011 Year 01 Month 12 Day

Last modified on

2018 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005661


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name